What are the treatment options for tremors?

Treatment Options for Tremors

First-Line Pharmacological Treatment for Essential Tremor

Propranolol (80-240 mg/day) or primidone are the first-line treatments for essential tremor, with demonstrated efficacy in up to 70% of patients. 1

Propranolol (Beta-Blocker)

• Propranolol is the most established medication for essential tremor, having been used for over 40 years with proven efficacy 2, 1
• Dosage range: 80-240 mg/day 1
• Also effective for tremor associated with thyrotoxicosis, hyperthyroidism, and Graves' disease 2
• Common adverse effects include fatigue, depression, nausea, dizziness, insomnia, cold extremities, and bronchospasm 1

Critical contraindications for propranolol:

• Chronic obstructive pulmonary disease 1, 3
• Bradycardia 1, 3
• Congestive heart failure 1, 3
• In elderly patients, excessive heart rate reduction may lead to serious adverse events 1

Primidone (Anticonvulsant)

• First-line option alongside propranolol, effective in up to 70% of patients 1, 3
• Therapeutic benefit can occur even when derived phenobarbital levels remain subtherapeutic, confirming primidone itself has anti-tremor properties 1
• Clinical benefits may not become apparent for 2-3 months, requiring an adequate trial period 1
• Side effects include behavioral disturbances, irritability, and sleep disturbances at higher doses 1
• Women of childbearing age must be counseled about teratogenic risks (neural tube defects) 1

When to Initiate Treatment

• Medications should only be initiated when tremor symptoms interfere with function or quality of life 1, 3

---

Second-Line Pharmacological Options

If first-line agents fail or are contraindicated, consider these alternatives:

Alternative Beta-Blockers

• Metoprolol: 25-100 mg extended release daily or twice daily 1
• Nadolol: 40-320 mg daily 1
• Atenolol: Limited evidence for moderate effect, with similar adverse effects to propranolol 1
• Timolol: 20-30 mg/day 1

Other Medications

• Topiramate: Second-line option with established efficacy 4
• Gabapentin: Limited evidence for moderate efficacy 1, 5
• Carbamazepine: May be used as second-line therapy, though generally not as effective as first-line options 1

Dual benefit consideration: For patients with both essential tremor and hypertension, beta-blockers provide treatment for both conditions 1, 3

---

Surgical Interventions for Medication-Refractory Tremor

Surgical therapies should be considered when medications fail due to lack of efficacy at maximum doses, dose-limiting side effects, or medical contraindications. 1

Treatment Algorithm for Surgical Candidates

For unilateral tremor or patients with medical comorbidities:

• Magnetic Resonance-Guided Focused Ultrasound (MRgFUS) thalamotomy is preferred due to lower complication rates 1, 3
• Shows sustained tremor improvement of 56% at 4 years 1, 3
• Lowest complication rate (4.4%) compared to radiofrequency thalamotomy (11.8%) and DBS (21.1%) 1, 3
• Early adverse effects include gait disturbance (36%) and paresthesias (38%), which decrease to 9% and 14% respectively by 1 year 1
• Serious adverse events are rare (1.6%), with most being mild or moderate (98.4%) 1

MRgFUS contraindications:

• Cannot undergo MRI 1, 3
• Skull density ratio <0.40 1, 3
• Bilateral treatment needed 1, 3
• Previous contralateral thalamotomy 1, 3

For bilateral tremor or MRgFUS contraindications:

• Deep Brain Stimulation (DBS) targeting the ventral intermediate nucleus (VIM) of the thalamus 1
• Provides adjustable, reversible tremor control that can be optimized over time 1
• Preferred for relatively young patients as it offers an adjustable treatment option 1
• Complication rate of 21.1% 1, 3

For patients who cannot undergo MRgFUS or DBS:

• Radiofrequency thalamotomy is available but carries higher complication risks (11.8%) 1, 3

---

Parkinson's Disease Tremor

For resting tremor associated with Parkinson's disease, levodopa/carbidopa is the primary treatment, not beta-blockers 6

• Levodopa crosses the blood-brain barrier and is converted to dopamine, relieving Parkinsonian symptoms including tremor 6
• Carbidopa inhibits peripheral decarboxylation of levodopa, making more available for brain transport 6
• Extended-release formulations provide steadier plasma levels, reducing motor fluctuations 6

---

Important Clinical Pitfalls

Avoid these common errors:

• Do not prescribe beta-blockers without screening for COPD, bradycardia, or heart failure 1, 3
• Do not expect immediate results with primidone; allow 2-3 months for full effect 1
• Do not use propranolol for Parkinson's disease tremor; use levodopa/carbidopa instead 6, 7
• Do not consider surgical options until maximizing medical therapy 1
• Regular assessment of tremor severity and medication side effects is essential, with dose adjustments based on clinical response and tolerability 1